These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17302365)

  • 21. Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Aug; 79(8):1095-102. PubMed ID: 17597485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
    Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases.
    Lin A; Kadam JS; Bodenheimer HC; Leonard J; Joyce MA; Lake-Bakaar G
    J Med Virol; 2008 Aug; 80(8):1350-3. PubMed ID: 18551608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment options for chronic hepatitis B and C infection in children.
    Hardikar W; Schwarz KB
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):583-91. PubMed ID: 17009938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel approaches for therapy of chronic hepatitis C.
    Stauber RE; Stadlbauer V
    J Clin Virol; 2006 Jun; 36(2):87-94. PubMed ID: 16546442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.
    Asselah T; Bièche I; Paradis V; Bedossa P; Vidaud M; Marcellin P
    Semin Liver Dis; 2007 Feb; 27(1):13-27. PubMed ID: 17295174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of viral hepatitis].
    Vucelić B
    Acta Med Croatica; 2003; 57(3):171-81. PubMed ID: 14582463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of chronic hepatitis C infection: one step at a time.
    Davis GL; Lindsay KL
    Lancet Infect Dis; 2005 Aug; 5(8):524-6. PubMed ID: 16048721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C and diabetes: one treatment for two diseases?
    Pattullo V; Heathcote J
    Liver Int; 2010 Mar; 30(3):356-64. PubMed ID: 20040049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of chronic hepatitis C in patients with renal disease.
    Gane E
    Med J Malaysia; 2005 Jul; 60 Suppl B():72-6. PubMed ID: 16108179
    [No Abstract]   [Full Text] [Related]  

  • 31. [Host factors determining the outcome of IFN treatment for chronic hepatitis C].
    Kiyosawa K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):481-4. PubMed ID: 15359845
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiviral therapy for hepatitis C: why are so few patients being treated?
    Volk ML
    J Antimicrob Chemother; 2010 Jul; 65(7):1327-9. PubMed ID: 20460398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing chronic hepatitis C in the difficult-to-treat patient.
    Kemmer N; Neff GW
    Liver Int; 2007 Dec; 27(10):1297-310. PubMed ID: 18036096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary prevention of hepatitis C virus-related hepatocellular carcinoma.
    Lin SM; Chu CM
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1475-7. PubMed ID: 16174061
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancing hepatitis C treatment uptake and outcomes for injection drug users.
    Dore GJ
    Hepatology; 2007 Jan; 45(1):3-5. PubMed ID: 17187427
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis C: What lies ahead and can we afford it?
    Howie H; Hutchinson SJ
    J Viral Hepat; 2004 Sep; 11 Suppl 1():28-33. PubMed ID: 15357861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of treatment non responders in chronic hepatitis C.
    Poynard T
    Med J Malaysia; 2005 Jul; 60 Suppl B():77-9. PubMed ID: 16108180
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimizing outcomes in hepatitis C: is treatment beyond 48 weeks ever justified?
    Fontana RJ
    Gastroenterology; 2006 Apr; 130(4):1357-62. PubMed ID: 16618429
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment options of patients with chronic hepatitis C who have failed prior therapy.
    Shah ND; Fried MW
    Clin Liver Dis (Hoboken); 2016 Feb; 7(2):40-44. PubMed ID: 31041026
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimizing treatment outcomes in chronic hepatitis C: management of non-response.
    Pol S; Bourlière M
    Antivir Ther; 2006; 11(8):955-70. PubMed ID: 17302365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.